Asthma Clinical Trial
Official title:
Improving Asthma Care for Minority Children in Head Start
This study will evaluate two interventions that are designed to reduce asthma morbidity and improve asthma care of children in Head Start in urban Baltimore.
BACKGROUND:
Asthma-related morbidity and mortality are disproportionately high among low-income African
American children. The effects of asthma are particularly harsh in very young children and
their families, resulting in high rates of emergency department care, hospitalization,
decreased quality of life, and the risk of fatal asthma. Research suggests that the
contributing factors to this high morbidity include under-use of asthma primary preventive
care, sub-optimal medical management, and inappropriate asthma management behaviors. Despite
the importance of early and regular asthma preventive care for children, this goal has proved
elusive. Head Start programs offer an ideal venue for accessing high-risk, low-income
preschool children and improving asthma morbidity. The study will test the hypothesis that
removing barriers to preventive asthma care and facilitating communication between parents
and primary care providers (PCP) are necessary prerequisites to optimally influence
caregiver's asthma management practices. The study will remove barriers by the use of
Breathmobile, a community-based service that is specifically designed to deliver asthma
screening and special consultation directly to families and children in high-risk
neighborhoods. In addition, the study will evaluate a caregiver/PCP communication
intervention designed to facilitate communication between parents and PCPs about a child's
asthma severity and recommended therapy.
DESIGN NARRATIVE:
This two times two modified factorial study design will compare the following in their
effectiveness in reducing asthma morbidity and improving asthma management: a Breathmobile
intervention combined with a Facilitated Asthma Communication intervention (FACI); a FACI
alone; the Breathmobile intervention alone; or a control group. A total of 360 Head Start
students ages 2 to 6 with symptomatic doctor-diagnosed asthma will be recruited. The primary
study outcome measure will be the number of symptom-free days over a period of 12 months.
Secondary outcomes include health care utilization (i.e., emergency department visits,
hospitalizations, and primary care visits), asthma medications, parent asthma-related quality
of life, parent asthma management practices, and cost-effectiveness. The study will test the
hypothesis that a FACI combined with the Breathmobile intervention will be the most effective
in improving parent and PCP management of the child's asthma and in reducing asthma
morbidity.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|